CG Oncology, Inc. - Common Stock (CGON) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2024 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
CGON on Nasdaq
Shares outstanding
76,566,375
Price per share
$53.42
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
81,119,106
Total reported value
$3,367,539,263
% of total 13F portfolios
0%
Share change
+1,330,221
Value change
+$57,933,854
Number of holders
192
Price from insider filings
$53.42
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CG Oncology, Inc. - Common Stock (CGON) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 8.6% $264,932,879 6,577,281 The Vanguard Group 30 Sep 2025
Decheng Capital Global Life Sciences Fund IV, L.P. 8.4% $178,215,582 6,371,669 Xiangmin Cui 31 Dec 2024
WELLINGTON MANAGEMENT GROUP LLP 7.2% $222,054,738 5,512,779 Wellington Management Group LLP 30 Sep 2025
Longitude Capital Partners IV, LLC 6% $121,032,477 4,662,268 Patrick G. Enright 11 Sep 2025
Unique Diamond Investments Ltd 5.5% $117,791,208 4,211,341 SONG, Hong Fang 31 Dec 2024
FMR LLC 5.1% $100,262,786 3,856,261 FMR LLC 30 Jun 2025
TCG Crossover GP I, LLC 4.8% $102,655,662 3,670,206 TCG Crossover GP I, LLC 31 Mar 2025
Seven Fleet Capital Management LP 2% $62,145,313 1,542,833 Brian Liu 06 Oct 2025
Seven Fleet Partners LP 1.9% $39,333,320 1,515,151 Seven Fleet Partners LP 11 Sep 2025

As of 31 Dec 2025, 192 institutional investors reported holding 81,119,106 shares of CG Oncology, Inc. - Common Stock (CGON). This represents 106% of the company’s total 76,566,375 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of CG Oncology, Inc. - Common Stock (CGON) together control 83% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 8.5% 6,539,482 -0.57% 0% $271,519,293
Decheng Capital LLC 8.3% 6,371,669 0% 36% $264,551,697
WELLINGTON MANAGEMENT GROUP LLP 7.8% 5,999,790 +8.8% 0.04% $249,111,280
BlackRock, Inc. 6.3% 4,843,242 +5.6% 0% $201,091,408
FMR LLC 5.6% 4,298,173 +11% 0.01% $178,460,143
TCG Crossover Management, LLC 4.8% 3,670,206 0% 5% $152,386,953
PRICE T ROWE ASSOCIATES INC /MD/ 4.5% 3,443,144 +117% 0.02% $142,961,000
STATE STREET CORP 3.9% 2,996,695 +46% 0% $124,422,776
Foresite Capital Management VI LLC 2.9% 2,221,474 0% 28% $92,235,600
RTW INVESTMENTS, LP 2.6% 2,012,127 +18% 0.84% $83,543,513
UBS Group AG 2.5% 1,923,746 -9.5% 0.02% $79,873,935
BRAIDWELL LP 2.4% 1,870,571 -43% 2.5% $77,666,108
ALLIANCEBERNSTEIN L.P. 2.1% 1,613,425 -25% 0.02% $66,989,406
FRANKLIN RESOURCES INC 2% 1,561,574 +6.3% 0.02% $64,836,553
ORBIMED ADVISORS LLC 2% 1,516,550 -12% 1.3% $62,967,156
GEODE CAPITAL MANAGEMENT, LLC 2% 1,511,533 +2.6% 0% $62,772,944
Avidity Partners Management LP 1.9% 1,472,699 -8% 18% $61,146,462
DV Trading LLC 1.9% 1,439,393 0% 5.2% $59,763,597
Pictet Asset Management Holding SA 1.8% 1,349,527 +2.3% 0.05% $56,032,361
GOLDMAN SACHS GROUP INC 1.7% 1,324,603 -3.1% 0.01% $54,997,517
BANK OF AMERICA CORP /DE/ 1.6% 1,190,053 +59% 0% $49,411,001
ACORN CAPITAL ADVISORS, LLC 1.5% 1,131,501 0% 16% $46,979,903
Polar Capital Holdings Plc 1.4% 1,098,662 0% 0.21% $45,616,446
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 1.4% 1,090,894 +40% 0.01% $45,293,919
Foresite Capital Management V, LLC 1.3% 1,004,050 0% 25% $41,688,156

Institutional Holders of CG Oncology, Inc. - Common Stock (CGON) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 81,119,106 $3,367,539,263 +$57,933,854 $41.52 192
2025 Q3 77,648,888 $3,127,517,509 +$92,134,469 $40.28 175
2025 Q2 75,914,566 $1,973,784,426 +$139,061,983 $26.00 161
2025 Q1 70,762,639 $1,735,652,621 +$98,334,837 $24.49 141
2024 Q4 66,057,386 $1,894,540,823 +$282,964,154 $28.68 137
2024 Q3 52,183,069 $1,962,909,867 +$277,213,171 $37.73 120
2024 Q2 43,274,514 $1,366,161,770 +$105,145,067 $31.57 109
2024 Q1 38,771,794 $1,702,050,758 +$1,700,470,138 $43.90 96